Selected Publications

Selected Publications

  1. Akimov Y, Bulanova D, Timonen S, Wennerberg K, Aittokallio T. Improved detection of differentially represented DNA barcodes for high-throughput clonal phenomics . Molecular Systems Biology 2020; 16: e9195. doi.org/10.15252/msb.20199195
  2. Ianevski A, Giri AK, Gautam P, Kononov A, Potdar S, Saarela J, Wennerberg K, Aittokallio T. Prediction of drug combination effects with a minimal set of experiments. Nature Machine Intelligence 2019; 1: 568–577. doi.org/10.1038/s42256-019-0122-4 PDF copy
  3. He L, Tang J, Andersson EI, Timonen S, Koschmieder S, Wennerberg K, Mustjoki S, Aittokallio T. Patient-customized drug combination prediction and testing for T-cell prolymphocytic leukemia patients. Cancer Research 2018; 78 (9): 2407-2418. doi: 10.1158 / 0008-5472.CAN-17-3644.
  4. Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, Khan SA, Peddinti G, Airola A, Pahikkala T, Mirtti T, Yu T, Bot BM, Shen L, Abdallah K, Norman T, Friend S , Stolovitzky G, Soule H, Sweeney CJ, Ryan CJ, Scher HI, Sartor O, Xie Y, Aittokallio T *, Zhou FL *, Costello JC *. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncology. 2017; 18 (1): 132-142. doi: 10.1016 / S1470-2045 (16) 30560-5. * Contributed equally as senior authors.
  5. Mpindi JP, Yadav B, Östling P, Gautam P, Malani D, Murumägi A, Hirasawa A, Kangaspeska S, Wennerberg K, Kallioniemi O, Aittokallio T. Consistency in drug response profiling . Nature 2016; 540 (7631): E5-E6. doi: 10.1038 / nature20171.